» Articles » PMID: 20065056

GES-13, a Beta-lactamase Variant Possessing Lys-104 and Asn-170 in Pseudomonas Aeruginosa

Overview
Specialty Pharmacology
Date 2010 Jan 13
PMID 20065056
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

GES-13 beta-lactamase, a novel GES variant possessing Lys-104 and Asn-170, was identified in Pseudomonas aeruginosa. bla(GES-13) was the single gene cassette of a class 1 integron probably located in the chromosome. GES-13 efficiently hydrolyzed broad-spectrum cephalosporins and aztreonam. Imipenem was a potent inhibitor of GES-13 but was not hydrolyzed at measurable rates.

Citing Articles

Novel Insights into Mobilome Reveal Extensive Genetic Variation in Hospital Effluents.

Conte D, Mesa D, Jove T, Zamparette C, Marques Sincero T, Palmeiro J Microbiol Spectr. 2022; 10(4):e0246921.

PMID: 35880869 PMC: 9430818. DOI: 10.1128/spectrum.02469-21.


Laboratory Variants GES, GES, and GES Increase Carbapenem Hydrolysis and Confer Resistance to Clavulanic Acid.

Piccirilli A, Mercuri P, Segatore B, Galleni M, Brisdelli F, Kerff F Antimicrob Agents Chemother. 2021; 65(6).

PMID: 33722888 PMC: 8315993. DOI: 10.1128/AAC.01931-20.


Molecular Characterization of Carbapenemase-Producing Pseudomonas aeruginosa of Czech Origin and Evidence for Clonal Spread of Extensively Resistant Sequence Type 357 Expressing IMP-7 Metallo-β-Lactamase.

Papagiannitsis C, Medvecky M, Chudejova K, Skalova A, Rotova V, Spanelova P Antimicrob Agents Chemother. 2017; 61(12).

PMID: 28993328 PMC: 5700319. DOI: 10.1128/AAC.01811-17.


Prevalence of ESBL-producing Pseudomonas aeruginosa isolates in Warsaw, Poland, detected by various phenotypic and genotypic methods.

Laudy A, Rog P, Smolinska-Krol K, Cmiel M, Sloczynska A, Patzer J PLoS One. 2017; 12(6):e0180121.

PMID: 28658322 PMC: 5489192. DOI: 10.1371/journal.pone.0180121.


In vitro prediction of the evolution of GES-1 β-lactamase hydrolytic activity.

Bontron S, Poirel L, Nordmann P Antimicrob Agents Chemother. 2015; 59(3):1664-70.

PMID: 25561336 PMC: 4325776. DOI: 10.1128/AAC.04450-14.


References
1.
Wachino J, Doi Y, Yamane K, Shibata N, Yagi T, Kubota T . Nosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel class a beta-lactamase, GES-3, in a neonatal intensive care unit in Japan. Antimicrob Agents Chemother. 2004; 48(6):1960-7. PMC: 415581. DOI: 10.1128/AAC.48.6.1960-1967.2004. View

2.
Smith C, Caccamo M, Kantardjieff K, Vakulenko S . Structure of GES-1 at atomic resolution: insights into the evolution of carbapenamase activity in the class A extended-spectrum beta-lactamases. Acta Crystallogr D Biol Crystallogr. 2007; 63(Pt 9):982-92. DOI: 10.1107/S0907444907036955. View

3.
Poirel L, Weldhagen G, Naas T, De Champs C, Dove M, Nordmann P . GES-2, a class A beta-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem. Antimicrob Agents Chemother. 2001; 45(9):2598-603. PMC: 90698. DOI: 10.1128/AAC.45.9.2598-2603.2001. View

4.
Power P, Galleni M, Ayala J, Gutkind G . Biochemical and molecular characterization of three new variants of AmpC beta-lactamases from Morganella morganii. Antimicrob Agents Chemother. 2006; 50(3):962-7. PMC: 1426437. DOI: 10.1128/AAC.50.3.962-967.2006. View

5.
Naas T, Poirel L, Nordmann P . Minor extended-spectrum beta-lactamases. Clin Microbiol Infect. 2007; 14 Suppl 1:42-52. DOI: 10.1111/j.1469-0691.2007.01861.x. View